Get the Stockscreener App
2.5478
5.64%
-0.1522
Anebulo Pharmaceuticals Inc stock is traded at $2.5478, with a volume of 102.34K.
It is down -5.64% in the last 24 hours and up +54.88% over the past month.
Anebulo Pharmaceuticals Inc is a clinical-stage biotechnology company, developing novel solutions for people suffering from cannabinoid overdose and substance addiction. The product candidate, ANEB-001, is intended to reverse the negative effects of cannabinoid overdose within 1 hour of administration. The signs and symptoms of cannabinoid overdose range from profound sedation to anxiety and panic to psychosis with hallucinations.
See More
Previous Close:
$2.70
Open:
$2.68
24h Volume:
102.34K
Relative Volume:
1.26
Market Cap:
$104.56M
Revenue:
-
Net Income/Loss:
$-7.92M
P/E Ratio:
-8.4927
EPS:
-0.3
Net Cash Flow:
$-7.05M
1W Performance:
-4.58%
1M Performance:
+54.88%
6M Performance:
+62.28%
1Y Performance:
+28.68%
1-Day Range:
$2.40
$2.6865
1-Week Range:
$2.40
$2.92
52-Week Range:
$0.8001
$3.39
Anebulo Pharmaceuticals Inc Stock (ANEB) Company Profile
Name
Anebulo Pharmaceuticals Inc
Sector
Industry
Phone
737 203 5270
Address
C/O ANEBULO PHARMACEUTICALS, INC., LAKEWAY
Compare ANEB with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ANEB
Anebulo Pharmaceuticals Inc
|
2.545 | 108.46M | 0 | -7.92M | -7.05M | -0.30 |
|
VRTX
Vertex Pharmaceuticals Inc
|
384.39 | 96.11B | 11.42B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.63 | 60.40B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
430.23 | 54.91B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
671.14 | 41.30B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
294.82 | 33.25B | 3.81B | -644.79M | -669.77M | -6.24 |
Anebulo Pharmaceuticals Inc Stock (ANEB) Latest News
Using fundamentals and technicals on Anebulo Pharmaceuticals Inc.Weekly Stock Market Strategy Summary - Newser
News impact scoring models applied to Anebulo Pharmaceuticals Inc.Weekly Breakout Forecast with Entry Zones - Newser
What makes Anebulo Pharmaceuticals Inc. stock price move sharplyChart Driven Opportunity Scanner with Alerts - Newser
Volume spikes in Anebulo Pharmaceuticals Inc. stock – what they meanSmart Chart Forecasting with AI Algorithms - Newser
Technical Models Detect Momentum Build in Anebulo Pharmaceuticals Inc.Pattern Alert With ROI Driven Strategy Shared - beatles.ru
Using AI based signals to follow Anebulo Pharmaceuticals Inc.Free Breakout Entry Signal Confirmation Tool - Newser
Will Anebulo Pharmaceuticals Inc. stock recover after recent dropFree Target Return Focused Trade Insights - Newser
How institutional ownership impacts Anebulo Pharmaceuticals Inc. stockFree Weekly Stock Opportunity Radar Scanner - Newser
What are Anebulo Pharmaceuticals Inc. company’s key revenue driversMarket-crushing profits - Jammu Links News
Is Anebulo Pharmaceuticals Inc. a growth stock or a value stockProven strategies for superior portfolio growth - Jammu Links News
What drives Anebulo Pharmaceuticals Inc. stock priceAchieve exceptional returns with expert guidance - Jammu Links News
What are the latest earnings results for Anebulo Pharmaceuticals Inc.Unstoppable profit momentum - Jammu Links News
What analysts say about Anebulo Pharmaceuticals Inc. stockExponential wealth increase - Jammu Links News
What is the dividend policy of Anebulo Pharmaceuticals Inc. stockPhenomenal capital gains - Jammu Links News
Is it the right time to buy Anebulo Pharmaceuticals Inc. stockGet timely market insights for better trades - Jammu Links News
Does Anebulo Pharmaceuticals Inc. stock perform well during market downturnsBuild a winning investment strategy today - Jammu Links News
What is Anebulo Pharmaceuticals Inc. company’s growth strategyExplosive capital appreciation - Jammu Links News
What are the technical indicators suggesting about Anebulo Pharmaceuticals Inc.Achieve rapid portfolio growth with smart picks - Jammu Links News
How volatile is Anebulo Pharmaceuticals Inc. stock compared to the marketInvest smarter with expert trading signals - Jammu Links News
Using Ichimoku Cloud for Anebulo Pharmaceuticals Inc. technicalsBear Market Safe Zone Technical Analysis - Newser
Published on: 2025-08-01 22:56:24 - metal.it
What are analysts’ price targets for Anebulo Pharmaceuticals Inc. in the next 12 monthsEarnings Report Guidance For Smart Trading - jammulinksnews.com
Analyzing Anebulo Pharmaceuticals Inc. with multi timeframe chartsMachine Learning Stock Movement Detector - Newser
How Resilient Is Anebulo Pharmaceuticals Inc. Stock During Economic DownturnsDaily Growth Stock Pick Reports Show Bullish Signals - metal.it
Screener Results Flag Anebulo Pharmaceuticals Inc. as OversoldConsistent Profit Pattern Recognition Tools Shared - metal.it
How Anebulo Pharmaceuticals Inc. stock performs during market volatilityFree Low Risk Swing Trade Opportunity List - Newser
Here's Why We're Not Too Worried About Anebulo Pharmaceuticals' (NASDAQ:ANEB) Cash Burn Situation - 富途牛牛
What institutional investors are buying Anebulo Pharmaceuticals Inc. stockAchieve rapid portfolio appreciation - Jammu Links News
Published on: 2025-07-28 00:00:23 - Jammu Links News
Anebulo Pharmaceuticals Inc Stock (ANEB) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.36%
1.76%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):